Apoptosis and its Role in Parkinson’s Disease
Open Access
- 22 December 2018
- book chapter
- Published by Codon Publications
Abstract
Parkinson’s disease is one of the most common neurodegenerative diseases in the elderly. The motor symptoms occur predominantly due to substantial dopamine depletion, caused by degeneration of the dopaminergic neurons in substantia nigra pars compacta. Apoptosis has been implicated as the main mechanism of neuronal death in Parkinson’s disease. Apoptosis is mediated by a number of initiator and executioner caspases, and occurs via the intrinsic or extrinsic pathways. Activation of initiator caspase-9 mediates the intrinsic pathway—also called the mitochondria-mediated pathway. Alternatively, activation of initiator caspase-8 mediates the extrinsic apoptotic pathway—the cell death receptor–mediated pathway. Both initiator caspases converge onto a common pathway of executioner caspases, involving caspase-3 and caspase-6. Activation of the executioner caspases leads to the morphological features characteristic of apoptosis, such as DNA cleavage and its subsequent fragmentation. Proapoptotic factors, such as Bax, have been implicated in neuronal cell death in Parkinson’s disease, and there is evidence that both the intrinsic and extrinsic apoptotic pathways may play a role. This chapter provides an overview of apoptosis and its significance in Parkinson’s disease.Keywords
This publication has 122 references indexed in Scilit:
- Infectious Agents and NeurodegenerationMolecular Neurobiology, 2012
- Genetics of Parkinson's DiseaseCold Spring Harbor Perspectives in Medicine, 2012
- Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease BrainJournal of Biological Chemistry, 2008
- Nature of Mitochondrial DNA Deletions in Substantia Nigra NeuronsAmerican Journal of Human Genetics, 2008
- Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesNature, 2006
- Wild-type PINK1 Prevents Basal and Induced Neuronal Apoptosis, a Protective Effect Abrogated by Parkinson Disease-related MutationsOnline Journal of Public Health Informatics, 2005
- Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brainJournal of Neural Transmission, 2000
- Simultaneous Degradation of αII- and βII-Spectrin by Caspase 3 (CPP32) in Apoptotic CellsOnline Journal of Public Health Informatics, 1998
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences of the United States of America, 1998
- Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase.The Journal of cell biology, 1994